Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray

Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters—a randomized, double‐blind, placebo‐controlled trial

(2019) Kamil Detyniecki et al.   EPILEPSIA

Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults

(2017) Alexander K. Berg et al.   EPILEPSY & BEHAVIOR

Pre-hospital midazolam for benzodiazepine-treated seizures before and after the Rapid Anticonvulsant Medication Prior to Arrival Trial: A national observational cohort study

(2017) Eytan Shtull-Leber et al.   PLoS One

Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers

(2015) Lindy L. Bancke et al.   EPILEPSIA

Midazolam as an anticonvulsant antidote for organophosphate intoxication-A pharmacotherapeutic appraisal

(2015) Sandesh D. Reddy et al.   EPILEPSIA

The safety and tolerability of intranasal midazolam in epilepsy

(2014) Marco Mula   Expert Review of Neurotherapeutics

Intranasal delivery of antiepileptic medications for treatment of seizures

(2009) Daniel P. Wermeling   Neurotherapeutics